Affinity Asset Advisors, LLC Astria Therapeutics, Inc. Transaction History
Affinity Asset Advisors, LLC
- $690 Million
- Q1 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 845,606 shares of ATXS stock, worth $8.01 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
845,606
Previous 1,466,465
42.34%
Holding current value
$8.01 Million
Previous $11.3 Million
5.64%
% of portfolio
1.72%
Previous 2.32%
Shares
7 transactions
Others Institutions Holding ATXS
# of Institutions
122Shares Held
48.8MCall Options Held
3.59MPut Options Held
483K-
Perceptive Advisors LLC New York, NY6.49MShares$61.4 Million1.91% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.28MShares$50 Million7.82% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$34.2 Million4.36% of portfolio
-
Black Rock Inc. New York, NY3.59MShares$34 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$33.7 Million7.97% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $144M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...